Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Apelian currently holds 11,000 shares of Eiger BioPharmaceuticals, Inc. (EIGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Apelian has been a net seller of EIGR stock. They have purchased $0 and sold $154.1K worth of shares.
David Apelian's most recent insider trade was on Aug 16, 2022, when they sold 5,000 shares at $9.81 per share.
David Apelian serves as Executive at Eiger BioPharmaceuticals, Inc. (EIGR). They have executed 6 insider transactions totaling $154.1K over their tenure at the company.
David Apelian holds the position of Executive at Eiger BioPharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
David Apelian has shown a selling trading pattern, with $0 in total purchases and $154.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Apelian was on Dec 30, 2015, when they sold $105.0K worth of ACHN shares. This transaction involved 10,000 shares at $10.50 per share.
David Apelian currently owns 11,000 shares of Eiger BioPharmaceuticals, Inc. (EIGR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Apelian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Apelian has 6 Form 4 filings on record as an insider at Eiger BioPharmaceuticals, Inc..
Set alerts for David Apelian and 40,000+ other insiders.